GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 833 filers reported holding GLAXOSMITHKLINE PLC in Q2 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $201,000 | -50.1% | 5,310 | -38.1% | 0.07% | -41.9% |
Q4 2019 | $403,000 | +59.3% | 8,582 | +44.8% | 0.12% | +45.9% |
Q3 2019 | $253,000 | -2.3% | 5,926 | -8.5% | 0.08% | -1.2% |
Q2 2019 | $259,000 | -7.8% | 6,477 | -3.6% | 0.09% | -11.3% |
Q1 2019 | $281,000 | -74.3% | 6,719 | -76.5% | 0.10% | -78.3% |
Q4 2018 | $1,092,000 | -0.5% | 28,567 | +4.6% | 0.45% | +17.6% |
Q3 2018 | $1,097,000 | -11.8% | 27,304 | -11.5% | 0.38% | -19.5% |
Q2 2018 | $1,244,000 | +4.7% | 30,849 | +1.5% | 0.47% | -1.9% |
Q1 2018 | $1,188,000 | +8.2% | 30,403 | -1.8% | 0.48% | +4.3% |
Q4 2017 | $1,098,000 | +0.5% | 30,960 | +15.1% | 0.46% | -5.3% |
Q3 2017 | $1,093,000 | -7.1% | 26,909 | -1.3% | 0.49% | -16.9% |
Q2 2017 | $1,176,000 | +5.8% | 27,275 | +3.4% | 0.59% | +1.7% |
Q1 2017 | $1,112,000 | +29.5% | 26,382 | +18.3% | 0.58% | +11.0% |
Q4 2016 | $859,000 | – | 22,309 | – | 0.52% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |